SCHEMBL20324914

SCHEMBL20324914

Nc1ncnn2c([C@H]3C[C@H](O[PH2]=O)[C@@H](COP(=O)(O)S)O3)cnc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 4/20 0.33
▸ P2RY2 P41231 3/20 0.33
▸ SRC P12931 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ DNPH1 O43598 1/20 0.33
▸ PRKAB2 O43741 1/20 0.33
▸ TRPM2 O94759 1/20 0.33
▸ LDHA P00338 1/20 0.33
▸ ADRB2 P07550 1/20 0.33
▸ FBP1 P09467 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ PRKAG1 P54619 1/20 0.33
▸ PRKAA2 P54646 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ PRKAA1 Q13131 1/20 0.33
▸ PDE3A Q14432 1/20 0.33
▸ TAS1R3 Q7RTX0 1/20 0.33
▸ TAS1R1 Q7RTX1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24539018 0.87 POLB (0.41) P2RY1P2RY2SRCSMN1; SMN2POLB
SCHEMBL20324585 0.83 DNPH1 (0.38) P2RY1P2RY2SRCSMN1; SMN2DNPH1
SCHEMBL20324789 0.80 STING1 (0.31) P2RY1P2RY2SRCSMN1; SMN2POLB
SCHEMBL23052587 0.76 NT5E (0.49) P2RY1POLBP2RX1P2RX3ALDH1A1
SCHEMBL20324787 0.73 POLB (0.44) P2RY2POLBSTING1
SCHEMBL22524022 0.72 POLB (0.43) P2RY2POLBSTING1
SCHEMBL21637014 0.72 DNPH1 (0.38) P2RY1P2RY2SRCSMN1; SMN2DNPH1
SCHEMBL17106826 0.71 — —
SCHEMBL17106740 0.71 ADRB1 (0.40) SMN1; SMN2POLBADORA1PDE4DPDE3A
SCHEMBL20325339 0.71 POLB (0.31) P2RY1P2RY2SRCSMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018118664-A1 COMBINATIONS OF PD-1 ANTAGONISTS AND CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT MERCK SHARP & DOHME CORP. (US) 2018-06-28 — — WO disclosed
Send feedback